Biocompatibility testing in Medical Devices Conference 2020 will give you the unique opportunity to discuss the most pressing issues and meet the representatives of the biggest companies and leaders from Biocompatibility and […]
Senzagen will be presenting a poster at the ASCCT meeting on Oct 20 from 4:45-6 pm EDT. Come join us to learn about how the GARDskin Dose-Response assay can be […]
In Vitro Skin Sensitization Testing with Human Relevance and High Accuracy In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for assessment […]
Wednesday, October 28, 2020 11:05 a.m. PT Joshua Schmidt, SenzaGen, Inc. "Leveraging in vitro to forecast in vivo success"
New Approach Methodology Use for Regulatory Application (NURA) in collaboration with the Association for the Advancement of Alternatives Assessment (A4) is hosting two half day trainings to explore practical solutions for the […]
Monday November 16, 2020 5:00 PM–6:30 PM EST Virtual Poster Session: Dose-Response Analysis in GARD for Assessment of Skin Sensitizer Potency Applicability of GARDskin for Accurate Assessment of Challenging Substances […]
This day is offering a theoretical base with different lectures on research forefront and financing opportunities. The workshop originally included a practical session on site, but due to the covid-19 […]
Dec. 1st at 1:10pm EDT As part of the "Sensitization: Skin & Beyond" science panel, Dr. Andy Forreryd at SenzaGen will be presenting a talk titled: "The GARD Platform for […]
In vitro, high accuracy, broad applicability Join this free webinar to learn how the GARD™ assays, based on genomics and machine learning, provide a highly accurate method for skin sensitization […]
User cases on hazard and potency assessment Join us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across […]
